The “High-Pressure Contrast Media Injectors Market – Competitive Analysis, Challenges, Drivers & Five Force Analysis” report has…
Category: Insights
World Stroke Day: Global survey reveals only 35% hospitals worldwide provide essential stroke treatment
On World Stroke Day, 29 October, the World Stroke Organization (WSO) is calling for urgent action…
Arbor Rapha Capital Bioholdings Corp. I Announces Pricing of $150 Million Initial Public Offering
Arbor Rapha Capital Bioholdings Corp. I (the “Company”) announced today that it priced its initial public offering…
TUT Fitness Group Grows International Sales Team for its Patented Resistance Band Technology & Home Gym Products
TUT Fitness Group Inc. (TSXV: GYM) (“TUT“) announced today that it has appointed fitness industry sales veteran, Stefan…
Molecular Lab Partners Announces Strong Third Quarter Results and Robust Q4 Pipeline
Molecular Lab Partners LLC, a national provider of turn-key Physician Office Laboratory (POL) Solutions, announced strong…
Ophthalmic Lens Market to grow by USD 3.21 bn from 2020 to 2024
The ophthalmic lens market is expected to grow by USD 3.21 bn from 2020 to 2024, progressing at…
United States Smart Insulin Pen Market Report 2021 Featuring Leading Players – Companion Medical, Diabnext, Digital Medics, Diamesco, & Emperra GmbH E-Health Technologies
The “United States Smart Insulin Pen Market and Forecast 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The United States…
United States Smart Insulin Pen Market Report 2021 Featuring Leading Players – Companion Medical, Diabnext, Digital Medics, Diamesco, & Emperra GmbH E-Health Technologies
The “United States Smart Insulin Pen Market and Forecast 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The United States…
Regulus Therapeutics Announces Strategic Prioritization of RGLS8429, its Next-Generation Candidate for the Treatment of Autosomal Dominant Polycystic Kidney Disease
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting…
Averix Bio, a Botanical-based Cannabinoid Supplier, Achieves cGMP 21 CFR Part 210 and Part 211 and ICH Q7 Compliance
Averix Bio is proud to announce that it has successfully completed an independent audit for 21 CFR…